161.90 +0.17 (0.11%)
After hours: 7:59PM EST
Previous Close | 162.38 |
Open | 161.32 |
Bid | 161.85 x 800 |
Ask | 162.20 x 800 |
Day's Range | 160.06 - 162.48 |
52 Week Range | 109.16 - 164.14 |
Volume | 6,814,703 |
Avg. Volume | 7,448,106 |
Market Cap | 425.761B |
Beta (5Y Monthly) | 0.70 |
PE Ratio (TTM) | 25.43 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 4.04 (2.49%) |
Ex-Dividend Date | Feb 22, 2021 |
1y Target Est | N/A |
U.S. regulators have approved the first long-acting drug combo for HIV, monthly shots that can replace the daily pills now used to control infection with the AIDS virus.
J&J; coronavirus vaccine has enough vaccine-trial data to begin analysis soon, Anthony Fauci said, according to a media report.
Russia’s Covid-19 vaccine, called Sputnik V, received its first emergency approval in the European Union on Thursday.